Joint Action

About 50% of people who have an anterior cruciate ligament (ACL) injury will go on to develop osteoarthritis later down the track. What determines who will go on to develop OA? And is it possible to reduce your risk of developing OA? On this week’s episode, Dr Adam Culvenor joins us to discuss.Dr Adam Culvenor is a Senior Research Fellow and Head of the Anterior Cruciate Ligament (ACL) Knee Injury Group within the La Trobe Sport and Exercise Medicine Research Centre. His research focuses on the outcomes of ACL injuries, in particular the prevention and management of early knee osteoarthritis in young adults following ACL injury and reconstruction.RESOURCESWebsitesLaTrobe University Sport and Exercise Medicine Research Centre BlogThe OPTIKNEE group is working to prevent osteoarthritis after knee injuryJournal articlesOPTIKNEE 2022: consensus recommendations to optimise knee health after traumatic knee injury to prevent osteoarthritisKnee Extensor Strength and Risk of Structural, Symptomatic, and Functional Decline in Knee Osteoarthritis: A Systematic Review and Meta-AnalysisEarly Knee Osteoarthritis Is Evident One Year Following Anterior Cruciate Ligament Reconstruction: A Magnetic Resonance Imaging EvaluationCONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast

Over the years, there has been good evidence that certain treatments are of little or no value, provide harm and have substantial costs associated with them. Arthroscopic partial meniscectomy (APM) is not a recommended treatment for osteoarthritis. Despite this, millions of these procedures are still being performed each year. On this week's episode of Joint Action we are joined by Professor Teppo Järvinen to discuss the evidence behind APM and evidence-based medicine.Professor Teppo Järvinen, an orthopaedic surgeon at the department of orthopaedics and trauma at Helsinki University and Helsinki University Central Hospital. Teppo led the Fidelity trial and has a strong interest in the “too much medicine” movement.CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast

Osteoarthritis is a highly prevalent disease affecting many developing and developed countries worldwide. The prevalence of OA depends on which joint is involved – whether it is the knee, hip or hand. Depending on what type of OA you have, it may also play a role in your overall health. On this week’s episode of Joint Action, we are joined by Qiang Liu to discuss the different sites of OA, their prevalence and risk factors.  Dr Qiang Liu is an orthopedic surgeon and associate professor who sees patients with joint diseases and does research on osteoarthritis in Peking University People’s Hospital. Qiang has published studies on the burden of osteoarthritis and exercise therapy for knee/hip osteoarthritis in prestige journals such as the Lancet Rheumatology and Osteoarthritis and Cartilage. Qiang has devoted himself to helping patients with osteoarthritis by applying and promoting strategies overlooked by the healthcare system in China. Together with Prof. Jianhao Lin, Qiang introduced the Good Life with Osteoarthritis from Denmark (GLA:DTM) to China together and has served as the program manager since 2017. They also opened the first private special clinic which focuses on delivering evidence-based non-surgical treatment for osteoarthritis in China. RESOURCESJournal articlesPrevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast